127 related articles for article (PubMed ID: 3705920)
1. Alteration of amino acids in cerebrospinal fluid from patients with Parkinson's disease and spinocerebellar degeneration.
Araki K; Takino T; Ida S; Kuriyama K
Acta Neurol Scand; 1986 Feb; 73(2):105-10. PubMed ID: 3705920
[TBL] [Abstract][Full Text] [Related]
2. A significant reduction of putative transmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease and spinocerebellar degeneration.
Tohgi H; Abe T; Hashiguchi K; Takahashi S; Nozaki Y; Kikuchi T
Neurosci Lett; 1991 May; 126(2):155-8. PubMed ID: 1681472
[TBL] [Abstract][Full Text] [Related]
3. [Cerebrospinal fluid methoxyhydroxy-phenylene glycol in Parkinson's disease and spinocerebellar degeneration (author's transl)].
Mizuno Y
No To Shinkei; 1979 Mar; 31(3):309-12. PubMed ID: 444338
[No Abstract] [Full Text] [Related]
4. [Cerebrospinal fluid homovanillic acid in paralysis agitans and spinocerebellar degeneration (author's transl)].
Mizuno Y; Ariga T
Rinsho Shinkeigaku; 1979 Jun; 19(6):367-71. PubMed ID: 477137
[No Abstract] [Full Text] [Related]
5. Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinson's disease.
Mally J; Szalai G; Stone TW
J Neurol Sci; 1997 Oct; 151(2):159-62. PubMed ID: 9349670
[TBL] [Abstract][Full Text] [Related]
6. Neurotransmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease.
Jiménez-Jiménez FJ; Molina JA; Vargas C; Gómez P; Navarro JA; Benito-León J; Ortí-Pareja M; Gasalla T; Cisneros E; Arenas J
J Neurol Sci; 1996 Sep; 141(1-2):39-44. PubMed ID: 8880690
[TBL] [Abstract][Full Text] [Related]
7. Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease.
Engelborghs S; Marescau B; De Deyn PP
Neurochem Res; 2003 Aug; 28(8):1145-50. PubMed ID: 12834252
[TBL] [Abstract][Full Text] [Related]
8. Gamma-aminobutyric acid (GABA) in cerebrospinal fluid.
Kuroda H
Acta Med Okayama; 1983 Jun; 37(3):167-77. PubMed ID: 6224397
[TBL] [Abstract][Full Text] [Related]
9. Isoelectric focusing and electrophoresis of the CSF proteins in tremor of different origins.
Stibler H; Kjellin KG
J Neurol Sci; 1976 Dec; 30(2-3):269-85. PubMed ID: 63543
[TBL] [Abstract][Full Text] [Related]
10. Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinson's disease.
Molina JA; Jiménez-Jiménez FJ; Gomez P; Vargas C; Navarro JA; Ortí-Pareja M; Gasalla T; Benito-León J; Bermejo F; Arenas J
J Neurol Sci; 1997 Sep; 150(2):123-7. PubMed ID: 9268238
[TBL] [Abstract][Full Text] [Related]
11. [Neurochemical investigation on spinocerebellar degeneration--metabolites of biogenic amines in the cerebrospinal fluids].
Arai M; Kurosawa T; Hiyamuta E; Okada M; Kanai A
Rinsho Shinkeigaku; 1983 Jun; 23(6):501-8. PubMed ID: 6652996
[No Abstract] [Full Text] [Related]
12. Effect of probenecid on levels of cyclic AMP in human cerebrospinal fluid.
Cramer H; Ng LK; Chase TN
J Neurochem; 1972 Jun; 19(6):1601-2. PubMed ID: 4338441
[No Abstract] [Full Text] [Related]
13. Free amino acids in the cerebrospinal fluid in old age and in Parkinson's disease.
Gjessing LR; Gjesdahl P; Dietrichson P; Presthus J
Eur Neurol; 1974; 12(1):33-7. PubMed ID: 4413508
[No Abstract] [Full Text] [Related]
14. Cerebrospinal fluid amino compounds in Parkinson's disease. Alterations due to carbidopa/levodopa.
Manyam BV; Ferraro TN; Hare TA
Arch Neurol; 1988 Jan; 45(1):48-50. PubMed ID: 3337677
[TBL] [Abstract][Full Text] [Related]
15. Alteration of amino acid content of cerebrospinal fluid from patients with epilepsy.
Araki K; Harada M; Ueda Y; Takino T; Kuriyama K
Acta Neurol Scand; 1988 Dec; 78(6):473-9. PubMed ID: 3223234
[TBL] [Abstract][Full Text] [Related]
16. Amino acid abnormalities in cerebrospinal fluid of patients with parkinsonism and extrapyramidal disorders.
Lakke JP; Teelken AW
Neurology; 1976 May; 26(5):489-93. PubMed ID: 944400
[TBL] [Abstract][Full Text] [Related]
17. Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
Manyam NV; Katz L; Hare TA; Gerber JC; Grossman MH
Arch Neurol; 1980 Jun; 37(6):352-5. PubMed ID: 6446278
[TBL] [Abstract][Full Text] [Related]
18. The CSF iron in patients with neurological diseases.
Kjellin KG
Acta Neurol Scand; 1967; 43(3):299-313. PubMed ID: 4227818
[No Abstract] [Full Text] [Related]
19. Cerebrospinal fluid GABA levels in various neurological and psychiatric diseases.
Kuroda H; Ogawa N; Yamawaki Y; Nukina I; Ofuji T; Yamamoto M; Otsuki S
J Neurol Neurosurg Psychiatry; 1982 Mar; 45(3):257-60. PubMed ID: 7086447
[TBL] [Abstract][Full Text] [Related]
20. Species fractionation in a case-control study concerning Parkinson's disease: Cu-amino acids discriminate CSF of PD from controls.
Willkommen D; Lucio M; Schmitt-Kopplin P; Gazzaz M; Schroeter M; Sigaroudi A; Michalke B
J Trace Elem Med Biol; 2018 Sep; 49():164-170. PubMed ID: 29472131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
